ACCURAY INC (ARAY) Form 424B3 — Sep 11, 2026
Accuray Incorporated filed a prospectus registering the resale by selling stockholders of up to 6,834,308 shares of common stock issuable upon exercise of Super Premium, Premium, and Penny Warrants issued to lenders under its senior secured Financing Agreement, in connection with an $18.25 million delayed draw term loan drawn on May 19, 2026. Accuray will receive no proceeds from the resales and only receives cash if the warrants are exercised for cash. The stock last traded at $0.24 per share on September 10, 2026, leaving the $0.01 penny warrants deeply in the money while the $1.25 and $1.50 premium warrants sit far out of the money.
Key figures
- Debt Amount
- $18.25 million (delayed draw term loan drawn May 19, 2026)
- Shares Offered
- 6834308
- Shares Outstanding
- 119433440
- Listing transfer
- From Nasdaq Global Select Market to Nasdaq Capital Markets effective August 6, 2026
- Warrant expiry range
- June 6, 2032 to July 29, 2033
- Premium warrant shares
- 2135721
- Last reported sale price
- $0.24 per share (September 10, 2026)
- Tcw rescue fund ownership
- 25,610,247 shares (21.44%)
- Anti dilution trigger prices
- ["$1.25","$1.12","$0.93","$1.00"]
- Penny warrant exercise price
- $0.01
- Super premium warrant shares
- 2990010
- July 2026 penny warrant shares
- 15253473
- Premium warrant exercise price
- $1.25
- Tcw affiliate lender principal
- $120 million
- June 2025 premium warrant shares
- 17180710
- Penny warrant shares this prospectus
- 1708577
- Super premium warrant exercise price
- $1.50
- June 2025 premium warrant exercise price
- $1.68
- Selling stockholders beneficial ownership
- 50,855,304 shares (42.58%)
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.